N-[4-(trifluoromethyl)phenyl]-5-methylisoxazole-4-carboxamide | |
---|---|
Trade Name | |
Orphan Indication | Ovarian cancer |
USA Market Approval | USA |
USA Designation Date | 1996-03-12 00:00:00 |
Sponsor | Sugen, Inc.;230 East Grand Ave.;South San Francisco, California, 94080 |